Qureator, Inc.
Qureator, Inc.
Qureator, Inc.
Home
Technologies
Disease Models
Cancer Metastasis
Cancer vTIME for Immunotherapy
Age-related Macular Degeneration (AMD)
Drug Induced Liver Injury (DILI)
Blood Brain Barrier (BBB)
Curiochips
AI
Therapeutic Applications
News
About
Contact
Home
Technologies
Disease Models
Cancer Metastasis
Cancer vTIME for Immunotherapy
Age-related Macular Degeneration (AMD)
Drug Induced Liver Injury (DILI)
Blood Brain Barrier (BBB)
Curiochips
AI
Therapeutic Applications
News
About
Contact
News & Publications
Qureator Featured in World Premiere of “The New Gold Standard” Documentary
June 25, 2026
|
Tags :
Spotlight
,
Qureator’s Historic FDA IND Approval Based on Human-Relevant Data Highlighted in The BIO
November 25, 2025
|
Tags :
Press highlights
,
Qureator and Physicians Committee for Responsible Medicine Showcases the Future of Toxicology at SOT 2026 Workshop
March 24, 2026
|
Tags :
News
Publications
Public Biddings
All
Activities
Press highlights
Spotlight
Select Category
All
Activities
Press highlights
Spotlight
Qureator Featured in World Premiere of “The New Gold Standard” Documentary
June 25, 2026
|
Tags :
Spotlight
,
Qureator and Physicians Committee for Responsible Medicine Showcases the Future of Toxicology at SOT 2026 Workshop
March 24, 2026
|
Tags :
Qureator Shortlisted for Prestigious Lush Prize in Science
January 12, 2026
|
Tags :
Spotlight
,
Paul Park Joins Qureator as Chief Business Officer
December 2, 2025
|
Tags :
Spotlight
,
Qureator and Physicians Committee for Responsible Medicine Announce Joint Workshop at SOT 2026
November 25, 2025
|
Tags :
Activities
,
Qureator’s Historic FDA IND Approval Based on Human-Relevant Data Highlighted in The BIO
November 25, 2025
|
Tags :
Press highlights
,
Qureator Launches First Anti–PD-1/L1 Combination and PD-1/VEGF Bispecific Campaigns with Special Launch Offer !!!
November 7, 2025
|
Tags :
Spotlight
,
Qureator Showcases Next-Generation Immuno-Oncology Platform at SITC 2025
October 28, 2025
|
Tags :
Activities
,
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
October 27, 2025
|
Tags :
Press highlights
,
Spotlight
,
Load More
up
